SCHEMBL6988884

SCHEMBL6988884

CC1OCC(=O)C1(C)NC(=O)C(CNC(=O)c1ccc(-c2cccs2)cc1)c1ccc(O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 3/20 0.36
CTSB P07858 2/20 0.36
DPP4 P27487 1/20 0.35
PREP P48147 1/20 0.35
CTSL P07711 2/20 0.35
CTSK P43235 2/20 0.35
HPGDS O60760 1/20 0.35
CHRM4 P08173 1/20 0.35
HDAC1 Q13547 4/20 0.34
KCNH2 Q12809 2/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
PTGER2 P43116 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
DRD2 P14416 3/20 0.33
DRD4 P21917 3/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983222 0.86 MAPK8 (0.31)
SCHEMBL6987871 0.85 CTSK (0.39) CTSKALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL6990056 0.85 OPRM1 (0.37) ALDH1A1OPRM1OPRD1HDAC6
SCHEMBL6988403 0.85 KMT2A (0.35) CTSKALDH1A1HPGDSMN1; SMN2OPRM1
SCHEMBL6989542 0.84 TP53 (0.40) CTSKALDH1A1
SCHEMBL6990082 0.83 MAPT (0.41) HDAC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL6752373 0.83 HPGDS (0.49) CTSSCTSBCTSLCTSKHPGDS
SCHEMBL6988433 0.82 TAS1R3 (0.35) CTSK
SCHEMBL6982132 0.82 TAOK1 (0.36) ALDH1A1KDM4E
SCHEMBL6988694 0.81 ATM (0.39) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed